Who is sponsoring NCT05660564?

NCT05660564 is sponsored by Sarah Magdy Abdelmohsen.

What drugs are being tested in NCT05660564?

Interventions in NCT05660564: DIGU Dorsal inlay preputial graft urethroplasty.

Is NCT05660564 still recruiting?

NCT05660564 is currently completed. Last updated 21 December 2022.

Last reviewed 2022-12-21 · How we verify

NCT05660564: Hypospadias

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preputial Graft Urethroplasty in Primary Repair of Hypospadias

Completed Last updated 21 December 2022

What this trial tests

trial testing DIGU Dorsal inlay preputial graft urethroplasty in Completed in 40 participants. Completed in 30 October 2019.

Timeline

1 May 2018

Primary endpoint
1 May 2018

30 October 2019

Quick facts

Lead sponsor	Sarah Magdy Abdelmohsen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 May 2018
Primary completion	1 May 2018
Estimated completion	30 October 2019
Sites	1 location across Egypt

Drugs / interventions tested

DIGU Dorsal inlay preputial graft urethroplasty

Conditions studied

Completed — all drugs for Completed →

Sponsor

Sarah Magdy Abdelmohsen

Who can join

Adults 6 Months to 8, any sex, with Completed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Hypospadias repair is debated. There has been no perfect procedure until this moment. A graft is sometimes needed to fundamentally strengthen the narrow urethral plate. Patients and methods: The study included a child who had primary distal or mid-penile hypospadias at the age of 6 months or more, a urethral plate less than 8 mm in a non-circumcised penis, and was operated on using the Snodgraft technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sarah Magdy Abdelmohsen trials

Trials by the same sponsor.

NCT05917236 — Biliary Atresia With Rare Associations, a Case Report · completed
NCT06759688 — Role of Low Carbohydrate Nutrient in Healing of Infected Diabetic Foot · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05660564 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sarah Magdy Abdelmohsen
Last refreshed: 21 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05660564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing